Publications found:
55,654
Sort by:
Waldenstrom Macroglobulinemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF WALDENSTROM MACROGLOBULINEMIA PIPELINE REPORT INCLUDES Panorama of Waldenstrom Macroglobulinemia pipeline markets including statistics on therapeutic drugs and companies involved Waldenstrom Macroglobulinemia Pipeline candidates across various development ...
August 2018
160 pages
Wegener Polyangiitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF WEGENER POLYANGIITIS PIPELINE REPORT INCLUDES Panorama of Wegener Polyangiitis pipeline markets including statistics on therapeutic drugs and companies involved Wegener Polyangiitis Pipeline candidates across various development ...
August 2018
50 pages
West Nile Virus Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF WEST NILE VIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of West Nile Virus Infections pipeline markets including statistics on therapeutic drugs and companies involved West Nile Virus Infections Pipeline candidates across ...
August 2018
50 pages
Western Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF WESTERN EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Western Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Western Equine Encephalitis Pipeline candidates across various development ...
August 2018
20 pages
Wilson Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF WILSON DISEASE PIPELINE REPORT INCLUDES Panorama of Wilson Disease pipeline markets including statistics on therapeutic drugs and companies involved Wilson Disease Pipeline candidates across various development ...
August 2018
40 pages
Women Infertility R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF WOMEN INFERTILITY PIPELINE REPORT INCLUDES Panorama of Women Infertility pipeline markets including statistics on therapeutic drugs and companies involved Women Infertility Pipeline candidates across various development ...
August 2018
150 pages
Xerostomia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF XEROSTOMIA PIPELINE REPORT INCLUDES Panorama of Xerostomia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Yellow Fever R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF YELLOW FEVER PIPELINE REPORT INCLUDES Panorama of Yellow Fever pipeline markets including statistics on therapeutic drugs and companies involved Yellow Fever Pipeline candidates across various development ...
August 2018
40 pages
Aspergillosis Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Aspergillosis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Aspergillosis pipeline products. DISEASE OVERVIEW Aspergillus is a general fungus type that causes ...
August 2018
90 pages
Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018
US$ 1,200.00
... is the main challenge in detecting and treating Burkholderia Infections disease. Individuals with low immunity levels and ... Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Burkholderia ...
August 2018
45 pages
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chagas Disease (American trypanosomiasis) pipeline products. DISEASE OVERVIEW Chagas disease, also known as American Trypanosomiasis, is one of the ...
August 2018
70 pages
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chikungunya (CHIKV) Infection pipeline products. DISEASE OVERVIEW Chikungunya fever is a viral fever, caused ...
August 2018
90 pages
Chlamydia Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Chlamydia Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chlamydia pipeline products. DISEASE OVERVIEW Chlamydia infections are caused by Chlamydia trachomatis bacteria. Worldwide, the ...
August 2018
60 pages
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptosporidiosis (crypto) pipeline products. DISEASE OVERVIEW Cryptosporidium is one of the most widespread intestinal ...
August 2018
30 pages
Diphtheria Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Diphtheria Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Diphtheria pipeline products. DISEASE OVERVIEW Global Diphtheria market is estimated to be around $4.5 billion in 2020 driven ...
August 2018
60 pages
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis A (HAV) Infection pipeline products. DISEASE OVERVIEW The disease is primarily ...
August 2018
35 pages
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis D (HDV) pipeline products. DISEASE OVERVIEW Hepatitis D virus (HDV) infection is a liver disease ...
August 2018
50 pages
Herpes Labialis Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Herpes Labialis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Herpes Labialis pipeline products. DISEASE OVERVIEW Herpes Labialis referred to as cold sores, is a widespread infection impacting ...
August 2018
35 pages
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Japanese Encephalitis (JEV) Infection pipeline products. DISEASE OVERVIEW Japanese encephalitis virus or JAVEX is a viral ...
August 2018
40 pages
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram-negative bacteria ...
August 2018
90 pages
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Leishmaniasis (Kala-azar) pipeline products. DISEASE OVERVIEW Leishmaniasis is one of the most researched areas among ...
August 2018
90 pages
Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018
US$ 1,200.00
... . SCOPE OF Q-FEVER (QUERY FEVER) PIPELINE REPORT INCLUDES Panorama of Q-Fever (Query Fever) pipeline markets including statistics on therapeutic drugs and companies involved Q-Fever (Query Fever) Pipeline candidates across various development phases ...
August 2018
30 pages
Rabies Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Rabies Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rabies pipeline products. DISEASE OVERVIEW Human rabies is rare but fatal disease causing 50,000 ...
August 2018
60 pages
Rotavirus Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Rotavirus Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rotavirus pipeline products. DISEASE OVERVIEW Rotavirus virus symptoms include diarrhea, nausea and stomach ...
August 2018
45 pages
Rubella (German measles) Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Rubella (German measles) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rubella (German measles) pipeline products. DISEASE OVERVIEW Rubella virus is one of the key ...
August 2018
30 pages
Tetanus Infection Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Tetanus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tetanus Infection pipeline products. DISEASE OVERVIEW Tetanus infection is spread through Clostridium tetani bacteria, which ...
August 2018
65 pages
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tularaemia (Rabbit Fever) pipeline products. DISEASE OVERVIEW Tularaemia or Francisella tularensis infection or Rabbit Fever is a catastrophic ...
August 2018
35 pages
Yellow Fever Drug Development Pipeline Study, H2 2018
US$ 1,200.00
Yellow Fever Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Yellow Fever pipeline products. DISEASE OVERVIEW Yellow fever is a mosquito-borne infection that ranges from ...
August 2018
40 pages